VINPOVERT TABLETS
VINPOVERT TABLETS
Product Details :
| Feature | Details |
|---|---|
| Product Name | VINPOVERT Tablets |
| Form | Tablets |
| Key Ingredient | Vinpocetine (typically 5 mg or as prescribed) |
| Core Benefits | Enhances brain circulation, improves memory and cognition |
| Mechanism of Action | Increases cerebral blood flow and oxygen utilization in brain cells |
| Support Areas | Cognitive decline, vascular dementia, vertigo, memory loss |
| Recommended Usage | 1 tablet 2–3 times daily or as directed by a physician |
| Target Audience | Elderly patients, individuals with neurological or vascular disorders |
| Packaging Type | Blister pack |
| Available Pack Sizes | 10x1x10 tablets |
Composition: Beta Histine 16mg + Vinpocetine 5mg + Piracetam 400mg Packing: 10X10 Alu-Alu Description : VINPOVERT Tablets contain Vinpocetine, a neuroprotective agent known for enhancing cerebral blood flow and improving brain metabolism. It is widely used in the management of age-related cognitive decline, memory loss, dizziness, vertigo, and vascular dementia. VINPOVERT helps improve alertness, mental clarity, and learning capacity by increasing oxygen and nutrient delivery to brain tissues. Safe for long-term use, it is especially beneficial for elderly individuals and those recovering from neurological conditions, under appropriate medical supervision.
Send Enquiry & Get Best Quote
VINPOVERT TABLETS: Enhancing Cognitive and Circulatory Health
Introduction VINPOVERT TABLETS, expertly developed by Chemo Biological, combine the therapeutic benefits of Beta Histine, Vinpocetine, and Piracetam into a powerful formula designed to improve cognitive function and circulatory health. Each component has been carefully selected to address specific health needs, making VINPOVERT TABLETS a crucial part of maintaining optimal brain health and enhancing blood flow. Packaged in a 10×10 Alu-Alu blister pack, these tablets are crafted to deliver consistent, effective treatment for conditions associated with cognitive impairments and circulatory issues.
Product Overview VINPOVERT TABLETS are formulated to provide synergistic effects through their active ingredients:
- Beta Histine (16mg): Primarily used to treat vertigo and associated conditions, Beta Histine improves blood flow in the inner ear, reducing the severity and frequency of vertigo symptoms.
- Vinpocetine (5mg): Known for its neuroprotective properties, Vinpocetine enhances cerebral blood flow and metabolism, improving brain function and memory.
- Piracetam (400mg): A nootropic agent that influences cognitive function, Piracetam enhances the brain’s oxygen supply and stimulates the central nervous system, improving learning, memory, and overall brain function.
Benefits of VINPOVERT TABLETS
- Enhanced Cognitive Function: Piracetam and Vinpocetine work together to increase cognitive abilities, enhance memory, and support overall brain health.
- Improved Circulatory Health: Vinpocetine improves cerebral blood flow, thereby enhancing oxygen and nutrient delivery to the brain.
- Management of Vertigo Symptoms: Beta Histine is effective in treating symptoms of vertigo, making these tablets ideal for patients suffering from Ménière’s disease and other related conditions.
Why Choose VINPOVERT TABLETS?
- Advanced Formulation: Combining these three active ingredients addresses multiple aspects of brain health and circulatory function, providing a comprehensive approach to treatment.
- High-Quality Manufacturing: Produced in GMP-certified facilities, ensuring that each tablet meets the highest standards of quality and efficacy.
- Ease of Use: The Alu-Alu packaging not only protects the tablets from environmental factors but also ensures convenience and portability.
Pharma Franchise Opportunity Chemo Biological offers a rewarding pharma franchise opportunity for VINPOVERT TABLETS. This initiative is designed for entrepreneurs who are keen to make a significant impact in the healthcare industry by promoting a product that supports cognitive and circulatory health.
Franchise Benefits
- Market Demand: The increasing awareness of cognitive health and the need for effective treatments for circulatory issues ensures a robust market demand for VINPOVERT TABLETS.
- Comprehensive Support: Franchise partners benefit from Chemo Biological’s extensive support, including marketing strategies, promotional materials, and product education to ensure successful market entry and sales.
- Exclusive Territories: Franchisees have the opportunity to obtain exclusive rights to market VINPOVERT TABLETS in designated areas, minimizing competition and maximizing profitability.
Ideal Franchise Candidates
- Pharmaceutical distributors specializing in neurology and cardiology products.
- Entrepreneurs with experience in the pharmaceutical sector looking to diversify their product offerings.
- Medical professionals who wish to provide their patients with innovative healthcare solutions.
Marketing and Promotion Strategies Effective promotion of VINPOVERT TABLETS should focus on:
- Educational Initiatives: Conducting seminars and workshops for healthcare professionals to educate them on the benefits and uses of VINPOVERT TABLETS.
- Digital Marketing: Utilizing online platforms to reach a broader audience, focusing on the unique benefits of the product’s combined ingredients.
- Patient Testimonials: Leveraging positive feedback from users who have experienced significant improvements in their conditions to build trust and credibility.
Conclusion VINPOVERT TABLETS from Chemo Biological are set to transform the approach to treating cognitive and circulatory health issues. We invite potential franchisees to join us as we distribute this essential medication, enhancing the lives of individuals suffering from cognitive impairments and circulatory conditions.
Contact Us For more information on our pharma franchise opportunities or to start distributing VINPOVERT TABLETS, please contact Chemo Biological and Osiante biotech sales@chemobiologicals.com. Join us in our mission to deliver comprehensive and innovative health solutions to the market.